JP2013544854A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544854A5
JP2013544854A5 JP2013542356A JP2013542356A JP2013544854A5 JP 2013544854 A5 JP2013544854 A5 JP 2013544854A5 JP 2013542356 A JP2013542356 A JP 2013542356A JP 2013542356 A JP2013542356 A JP 2013542356A JP 2013544854 A5 JP2013544854 A5 JP 2013544854A5
Authority
JP
Japan
Prior art keywords
heteroaryl
group
independently selected
compound
substituents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2013542356A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013544854A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2011/083465 external-priority patent/WO2012075917A1/en
Publication of JP2013544854A publication Critical patent/JP2013544854A/ja
Publication of JP2013544854A5 publication Critical patent/JP2013544854A5/ja
Withdrawn legal-status Critical Current

Links

JP2013542356A 2010-12-06 2011-12-05 化合物 Withdrawn JP2013544854A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2010/079463 2010-12-06
CN2010079463 2010-12-06
PCT/CN2011/083465 WO2012075917A1 (en) 2010-12-06 2011-12-05 Compounds

Publications (2)

Publication Number Publication Date
JP2013544854A JP2013544854A (ja) 2013-12-19
JP2013544854A5 true JP2013544854A5 (cg-RX-API-DMAC10.html) 2015-01-29

Family

ID=46206620

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013542356A Withdrawn JP2013544854A (ja) 2010-12-06 2011-12-05 化合物

Country Status (4)

Country Link
US (1) US8859573B2 (cg-RX-API-DMAC10.html)
EP (1) EP2649050A4 (cg-RX-API-DMAC10.html)
JP (1) JP2013544854A (cg-RX-API-DMAC10.html)
WO (1) WO2012075917A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY33766A (es) * 2010-12-06 2012-06-29 Glaxo Group Ltd COMPUESTOS CON ESTRUCTURA DE PIRIMIDINONA PARA USO EN EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR Lp-PLA2
MY172885A (en) 2011-09-01 2019-12-13 Glaxo Group Ltd Novel crystal form
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
WO2014063642A1 (zh) 2012-10-25 2014-05-01 中国中化股份有限公司 取代嘧啶类化合物及其用途
WO2014114249A1 (en) * 2013-01-25 2014-07-31 Glaxosmithkline Intellectual Property Development Limited Bicyclic pyrimidone compounds as inhibitors of lp-pla2
PE20151251A1 (es) * 2013-01-25 2015-09-10 Glaxosmithkline Ip Dev Ltd Derivados [5,6] biciclicos de imidazo pirimidona con actividad sobre enzimas lp-pla2
EP2764866A1 (en) 2013-02-07 2014-08-13 IP Gesellschaft für Management mbH Inhibitors of nedd8-activating enzyme
CA2943363A1 (en) 2014-04-02 2015-10-08 Intermune, Inc. Anti-fibrotic pyridinones
CN105777653A (zh) 2014-12-26 2016-07-20 中国科学院上海药物研究所 用作Lp-PLA2抑制剂的嘧啶酮类化合物及其药物组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1028955B1 (en) * 1997-11-06 2003-07-16 SmithKline Beecham plc Pyrimidinone compounds and pharmaceutical compositions containing them
US6559155B1 (en) * 1998-08-21 2003-05-06 Smithkline Beecham P.L.C. Pyrimidinone derivatives for the treatment of atherosclerosis
ATE437862T1 (de) * 2000-02-16 2009-08-15 Smithkline Beecham Plc Pyrimidin-5-onderivate als ldl-pla2 inhibitoren
GB0024808D0 (en) * 2000-10-10 2000-11-22 Smithkline Beecham Plc Novel compounds
EP1351691A4 (en) * 2000-12-12 2005-06-22 Cytovia Inc SUBSTITUTED 2-ARYL-4-ARYLAMINOPYRIMIDINES AND ANALOGUES AS ACTIVATORS OF CASPASES AND APOPTOSIS INDUCERS, AND USE THEREOF
US7973060B2 (en) 2005-10-13 2011-07-05 Crystalgenomics, Inc. Fab I inhibitor and process for preparing same
UY33766A (es) * 2010-12-06 2012-06-29 Glaxo Group Ltd COMPUESTOS CON ESTRUCTURA DE PIRIMIDINONA PARA USO EN EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR Lp-PLA2

Similar Documents

Publication Publication Date Title
JP2013544854A5 (cg-RX-API-DMAC10.html)
JP2013537203A5 (cg-RX-API-DMAC10.html)
JP2014508811A5 (cg-RX-API-DMAC10.html)
JP2013544860A5 (cg-RX-API-DMAC10.html)
JP2009544635A5 (cg-RX-API-DMAC10.html)
JP2010031025A5 (cg-RX-API-DMAC10.html)
JP2013501720A5 (cg-RX-API-DMAC10.html)
JP2013540712A5 (cg-RX-API-DMAC10.html)
JP2015512931A5 (cg-RX-API-DMAC10.html)
JP2008535903A5 (cg-RX-API-DMAC10.html)
JP2013505969A5 (cg-RX-API-DMAC10.html)
JP2011509261A5 (cg-RX-API-DMAC10.html)
JP2017509689A5 (cg-RX-API-DMAC10.html)
JP2013510120A5 (cg-RX-API-DMAC10.html)
JP2007077157A5 (cg-RX-API-DMAC10.html)
JP2014525420A5 (cg-RX-API-DMAC10.html)
JP2016516043A5 (cg-RX-API-DMAC10.html)
JP2012505234A5 (cg-RX-API-DMAC10.html)
JP2012505891A5 (cg-RX-API-DMAC10.html)
JP2013542261A5 (cg-RX-API-DMAC10.html)
JP2014507455A5 (cg-RX-API-DMAC10.html)
JP2013514367A5 (cg-RX-API-DMAC10.html)
JP2016531126A5 (cg-RX-API-DMAC10.html)
JP2012507535A5 (cg-RX-API-DMAC10.html)
JP2012512863A5 (cg-RX-API-DMAC10.html)